Krebs Biochemicals & Industries Limited (NSE:KREBSBIO)
India
· Delayed Price · Currency is INR 74.25
+0.12 (0.16%)
May 28, 2025, 3:29 PM IST
NSE:KREBSBIO Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Operating Revenue | 433.12 | 504.22 | 521.34 | 597.03 | 386.06 | Upgrade
|
| Other Revenue | - | - | - | - | 140.77 | Upgrade
|
| Revenue | 433.12 | 504.22 | 521.34 | 597.03 | 526.84 | Upgrade
|
| Revenue Growth (YoY) | -14.10% | -3.29% | -12.68% | 13.32% | 62.63% | Upgrade
|
| Cost of Revenue | 55.56 | 93.99 | 277.16 | 441.18 | 515.96 | Upgrade
|
| Gross Profit | 377.56 | 410.23 | 244.19 | 155.85 | 10.87 | Upgrade
|
| Selling, General & Admin | 165.98 | 170.53 | 165.32 | 159.81 | 167.75 | Upgrade
|
| Other Operating Expenses | 354.79 | 323.98 | 231.74 | 328.01 | 12.6 | Upgrade
|
| Operating Expenses | 587.66 | 562.17 | 462.65 | 550.79 | 232.39 | Upgrade
|
| Operating Income | -210.1 | -151.95 | -218.46 | -394.94 | -221.52 | Upgrade
|
| Interest Expense | -59.14 | -46.86 | -29.71 | -53.85 | -62.72 | Upgrade
|
| Interest & Investment Income | - | 1.56 | 1.27 | 3.58 | 0.72 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | -0.04 | -0.02 | -0.06 | -0.07 | Upgrade
|
| EBT Excluding Unusual Items | -269.24 | -197.28 | -246.92 | -445.27 | -283.59 | Upgrade
|
| Pretax Income | -269.24 | -197.28 | -246.92 | -445.27 | -283.59 | Upgrade
|
| Income Tax Expense | 0.15 | - | - | - | - | Upgrade
|
| Net Income | -269.39 | -197.28 | -246.92 | -445.27 | -283.59 | Upgrade
|
| Net Income to Common | -269.39 | -197.28 | -246.92 | -445.27 | -283.59 | Upgrade
|
| Shares Outstanding (Basic) | 22 | 22 | 22 | 22 | 20 | Upgrade
|
| Shares Outstanding (Diluted) | 22 | 22 | 22 | 22 | 20 | Upgrade
|
| Shares Change (YoY) | 0.04% | - | - | 9.89% | 9.00% | Upgrade
|
| EPS (Basic) | -12.49 | -9.15 | -11.45 | -20.65 | -14.45 | Upgrade
|
| EPS (Diluted) | -12.49 | -9.15 | -11.45 | -20.65 | -14.45 | Upgrade
|
| Free Cash Flow | -114.54 | -71.11 | -398.71 | -442.95 | -400.81 | Upgrade
|
| Free Cash Flow Per Share | -5.31 | -3.30 | -18.49 | -20.54 | -20.43 | Upgrade
|
| Gross Margin | 87.17% | 81.36% | 46.84% | 26.11% | 2.06% | Upgrade
|
| Operating Margin | -48.51% | -30.14% | -41.90% | -66.15% | -42.05% | Upgrade
|
| Profit Margin | -62.20% | -39.13% | -47.36% | -74.58% | -53.83% | Upgrade
|
| Free Cash Flow Margin | -26.45% | -14.10% | -76.48% | -74.19% | -76.08% | Upgrade
|
| EBITDA | -143.21 | -86.12 | -154.71 | -338.36 | -172.88 | Upgrade
|
| EBITDA Margin | -33.06% | -17.08% | -29.68% | -56.67% | -32.81% | Upgrade
|
| D&A For EBITDA | 66.89 | 65.83 | 63.75 | 56.58 | 48.64 | Upgrade
|
| EBIT | -210.1 | -151.95 | -218.46 | -394.94 | -221.52 | Upgrade
|
| EBIT Margin | -48.51% | -30.14% | -41.90% | -66.15% | -42.05% | Upgrade
|
| Revenue as Reported | 440.21 | 508.73 | 527.55 | 608.59 | 543.22 | Upgrade
|
| Advertising Expenses | - | - | - | - | 0.05 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.